Community Health Systems, Inc. CYH

2.94 0.06 2.08% as of 25 Sep
Market cap
$406.1M
P/E
1.6×

Insider Decisions

Total sells 0.12
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — 1 —
Insider Ownership 19.04%

Capital & Financial Ratios

Market Cap 406.11
Revenue 11,983.00
Net Income 410.00
Free Cash Flow (182.00)
Net Debt 9,429.00
Current Ratio 1.53
Debt/Equity (8.23)
P/E ratio 1.56
P/S ratio 0.03
P/B ratio 0.00
Past 5Y EPS Growth 8.02%
This Y EPS Growth (194.69%)
Next Y EPS Growth 59.01%
Next 5Y EPS Growth 49.85%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 38 37 260 149
Receivables 2,231 2,286 2,077 2,143
Inventory 328 331 322 271
Other 275 358 381 308
3,208 3,301 3,234 3,081
2023 2024 2025 Q'26
Payables 912 913 842 713
ST’ Debt 21 20 16 26
Other — — — —
2,142 2,345 2,208 2,016
in millions of $

Compound Annual Growth

10y 5y 3y
Sales (4.33%) 1.15% 0.74%
Cash Flow (5.15%) (24.26%) 21.87%
Earnings 12.41% (0.08%) 122.84%
Book Value 0.00% 0.00% 0.00%

Revenue

Mar Jun Sep Dec Year
’26 2,965 2,825 — — —
’25 3,159 3,133 3,087 3,106 12,485
’24 3,140 3,140 3,090 3,264 12,634
’23 3,108 3,115 3,086 3,181 12,490
’22 3,111 2,934 3,025 3,141 12,211
’21 3,013 3,007 3,115 3,233 12,368
’20 3,025 2,519 3,126 3,119 11,789
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (297) 88 — — —
’25 120 88 69 266 543
’24 96 101 67 216 480
’23 5 86 29 90 210
’22 101 53 137 9 300
’21 101 179 120 (531) (131)
’20 57 1,653 392 76 2,178
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (373) 12 — — —
’25 35 2 7 172 216
’24 4 16 (2) 107 125
’23 (112) 0 (98) (19) (229)
’22 4 (34) 67 (114) (77)
’21 (2) 73 2 (663) (590)
’20 (42) 1,562 269 (47) 1,742
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (0.43) 0.51 — — —
’25 (0.10) 2.09 0.96 0.81 3.77
’24 (0.32) (0.10) (2.95) (0.53) (3.90)
’23 (0.40) (0.29) (0.69) 0.35 (1.02)
’22 (0.01) (2.52) (0.32) 3.18 0.35
’21 (0.51) 0.04 0.85 1.34 1.76
’20 0.15 0.61 0.97 2.57 4.39
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

3.2
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
4.15 3.85 2.48 1.79 2.25 7.01 1.88 2.01 2.51 2.24

Analyst estimates 2026–2028

Powerpack
Low Price
22.56 10.51 6.36 5.35 11.04 17.04 14.74 8.01 6.29 4.47
High Price
120,000 113,000 87,000 80,000 70,000 66,000 66,000 61,000 60,000 57,000
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
18,438 15,353 14,155 13,210 11,789 12,368 12,211 12,490 12,634 12,485
Revenue
83.67% 82.60% 83.36% 83.72% 83.35% 83.49% 83.83% 84.04% 84.60% 85.07%
Gross Margin
(1,715) (2,833) (715) (430) 422 499 349 207 (283) 724
EBT
(9.30%) (18.45%) (5.05%) (3.26%) 3.58% 4.03% 2.86% 1.66% (2.24%) 5.80%
EBT Margin
(1,626) (2,396) (704) (590) 607 368 179 16 (362) 676
Net Income
1,100 861 700 608 558 540 534 505 486 426
Depreciation
166.51 137.36 125.57 116.14 102.08 97.57 94.80 95.75 95.64 93.48
Revenue/Sh
(15.54) (2.00) (6.99) (5.93) 4.43 1.82 0.35 (1.02) (3.90) 3.81
Earnings/Sh
10.27 6.92 2.43 3.38 18.86 (1.03) 2.33 1.61 3.63 4.07
Cash Flow/Sh
(6.58) (4.98) (4.60) (3.82) (3.78) (3.62) (2.93) (3.37) (2.69) (2.45)
Capex/Sh
3.68 1.93 (2.17) (0.44) 15.08 (4.65) (0.60) (1.76) 0.95 1.62
Free CF/Sh
15.61 (6.19) (12.98) (18.82) (13.32) (10.18) (9.90) (8.79) (12.69) (8.68)
Book Value/Sh
111 112 113 114 115 127 129 130 132 134
Shares
0.00 0.00 0.00 0.00 1.70 7.39 12.22 0.00 0.00 0.82
PE Ratio
0.03 0.03 0.02 0.03 0.07 0.14 0.05 0.03 0.03 0.03
PS Ratio
0.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PB Ratio
0.85 0.90 0.97 1.02 0.97 1.08 0.99 0.95 0.93 0.85
EV/Sales
38.36 64.12 (55.99) (270.38) 6.54 (22.58) (156.93) (51.80) 94.48 48.86
EV/FCF
1,137 773 274 385 2,178 (131) 300 210 480 543
Op' Cash Flow
(729) (557) (519) (435) (436) (459) (377) (439) (355) (327)
Capex
408 216 (245) (50) 1,742 (590) (77) (229) 125 216
FCF
1,779 1,712 1,157 1,145 1,695 1,115 896 1,066 956 1,026
Working Cap'
15,244 13,913 13,596 13,405 12,216 12,140 11,635 11,487 11,452 10,396
Total Debt
15,006 13,350 13,400 13,189 10,540 11,633 11,517 11,449 11,415 10,136
Net Debt
1,728 (692) (1,463) (2,141) (1,538) (1,290) (1,275) (1,147) (1,676) (1,159)
Sh' Equity
(7.09%) (12.48%) (4.73%) (4.29%) 3.23% 1.47% 0.31% (0.91%) (3.62%) 3.73%
ROA
(3.21%) (9.27%) 1.09% 3.68% 7.82% 8.47% 5.01% 5.81% 3.48% 10.36%
ROIC
(59.01%) (474.71%) 73.13% 37.46% (27.78%) (16.27%) (3.59%) 10.98% 36.56% (35.91%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Community Health Systems, Inc. peers in Medical Care Facilities

All 55 Medical Care Facilities stocks →

Community Health Systems, Inc. (CYH) key facts

  • Community Health Systems, Inc. (CYH) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
  • Community Health Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.5 billion, down 1.18% from fiscal 2024.
  • As of September 25, 2026, CYH traded at $2.94, a market capitalization of $406.1 million.
  • Return on equity was −35.9% and debt-to-equity -8.23.

Source: company filings (standardised) and stockrow calculations.

Community Health Systems, Inc. (CYH) Latest News

News by impact score

Fine-tune

25 Sep

3

Community Health Systems posted a mixed Q2 2026. Same-store net revenues rose 2.4% y/y and adjusted admissions grew 2.9%, but roughly half of the admissions gain came from uninsured patients, limiting revenue gains. Net revenue per adjusted admission fell 0.5% as payer mix weakened. Elective procedures remained the key swing factor: same-store surgeries were down 0.1% (inpatient down 3.8%), with orthopedic and cardiac procedures under pressure, though June volumes improved and clinic visits/MRI activity stayed solid, implying delayed demand rather than lost demand. Unfavorable mix and higher uncompensated care weighed on margins; adjusted EBITDA declined to $330M from $380M. Cash flow was $87M amid slower payer payments. CYH guides 2026 revenue to $11.4-$11.6B and adjusted EBITDA to $1.30-$1.375B. Improvement in elective volumes and payer timing could help, while margin recovery hinges on labor-cost control. Elective-demand softness and weak payer mix weigh on margins and cash flow, with only modest near-term upside unless volumes and reimbursement timing improve.

24 Jul

3

Rise in uninsured patients reduced Community Health Systems' Q2 financial results. Uninsured patient growth directly cuts revenue and margins for the hospital operator.

23 Jul

3

Community Health Systems Inc (CYH) Q2 2026 earnings call highlighted ongoing revenue navigation efforts amid operational and market pressures. Q2 earnings discussion addresses revenue challenges that may moderately affect near-term financial outlook and investor views.

3 transcript

Community Health Systems Q2 earnings call highlights financial results, operational metrics and outlook. Q2 earnings updates supply financial and operational details that can shift short-term investor views.

3

Community Health Systems posted wider-than-expected Q2 loss and lowered its 2026 outlook. Wider Q2 loss and lowered 2026 guidance point to weaker financial performance that can pressure near-term stock valuation.

3

Community Health Systems, Inc. issued its Q2 2026 earnings call summary covering quarterly results and outlook. Quarterly earnings updates deliver financial metrics and guidance that can shift near-term investor sentiment for CYH.

22 Jul

4

Community Health Systems reported financial results for the second quarter ended June 30, 2026. Quarterly earnings directly shape near-term stock valuation and investor outlook for the company.

3

Community Health Systems (CYH) Q2 earnings key metrics are compared to estimates. Q2 earnings metrics versus estimates reveal financial results that may influence near-term stock movement and investor views.

3

Community Health Systems reported a Q2 loss and missed revenue estimates. Q2 loss and revenue shortfall may pressure near-term stock performance and sentiment.

16 Jul

3

Community Health Systems faces Q2 earnings pressure from lower admissions, with potential offset from higher occupancy rates. Q2 earnings analysis for CYH highlights admission and occupancy trends affecting near-term financial outlook.

23 Jun

3

Community Health Systems works to reduce its debt load via asset sales, cost cuts and refinancing moves that target improved liquidity and lower interest expenses amid ongoing industry pressures. Debt reduction steps can moderately influence financial results and market sentiment but are unlikely to alter the company's overall trajectory.

3

Community Health Systems (CYH) stock faces split analyst revisions amid concerns over new CMS rules. CMS rule concerns trigger mixed analyst revisions with moderate effects on CYH operations and sentiment.

7 Jun

4

CMS proposal alters Community Health Systems (CYH) investment outlook through direct effects on operations, reimbursement rates and strategic positioning. CMS regulatory proposal drives major shifts in CYH reimbursement model and investor valuation.

2 Jun

3

Community Health Systems, Inc. sold four Arkansas hospitals for $110 million, directing proceeds toward debt reduction. Asset sale cuts debt by $110 million while shrinking hospital operations.

1 Jun

3

Freeman completes acquisition of 4 Northwest Arkansas hospitals. Hospital divestitures reshape CYH asset base and regional operations.

6 May

4

Community Health Systems, Inc. announced early tender results for its tender offer on certain outstanding senior secured notes. Early tender results on senior secured notes represent a major strategic debt management move that could significantly improve CYH's balance sheet and market perception.

23 Apr

4

Community Health Systems Q1 earnings call highlights key financial results, operational updates, and forward guidance for the hospital operator. Q1 earnings highlights reveal financial performance and strategic outlook that significantly shape investor expectations and stock trajectory.

4

Community Health Systems Inc (CYH) Q1 2026 earnings call highlights strategies for navigating operational challenges. Q1 2026 earnings highlights disclose financial results and strategic responses to challenges, likely significantly impacting CYH's future performance and market sentiment.

3

Community Health Systems' (CYH) first-quarter earnings were dragged down by flagging patient volumes. Declining first-quarter patient volumes negatively affected CHS earnings and short-term financial performance.

22 Apr

4

Community Health Systems, Inc. announced the commencement of a tender offer for certain outstanding senior secured notes. Tender offer for senior secured notes signals major debt management strategy that could reshape balance sheet and boost investor confidence.

4

Community Health Systems Inc. (CYH) reported a wider-than-expected first-quarter loss and missed sales estimates. Wider Q1 loss and sales miss signal financial weakness, likely eroding investor confidence and pressuring stock performance.

4

Community Health Systems posted a wider-than-expected Q1 net loss of $119.6 million, or $0.21 per share, versus analyst estimates of $68.7 million loss. Revenue fell 11% to $2.9 billion, missing forecasts of $3.01 billion, due to divestitures and lower patient volumes. Wider Q1 loss and revenue miss highlight persistent operational challenges and divestiture impacts, significantly pressuring near-term financial trajectory and investor sentiment.

4

Community Health Systems, Inc. (CYH) released Q1 2026 earnings call summary detailing financial results, operational updates, and future outlook. Q1 earnings call summary reveals financial performance and strategic directions significantly impacting CYH's market trajectory and investor sentiment.

21 Apr

4

Community Health Systems, Inc. announced first quarter 2026 results ended March 31, detailing financial performance for the period. Quarterly earnings announcements significantly affect financial metrics, investor sentiment, and stock trajectory.

3

Key metrics from Community Health Systems (CYH) Q1 earnings reveal insights into the company's financial performance, highlighting areas of strength and concern for investors. Q1 earnings metrics analysis moderately influences CYH's financial performance perception and short-term market sentiment.

3

Community Health Systems (CYH) reported a Q1 net loss of $25 million, or $0.22 per share, compared to a profit last year, with revenue of $3.00 billion missing estimates of $3.09 billion due to lower patient volumes and higher costs. Quarterly loss and revenue shortfall indicate financial strain from declining admissions and rising expenses, moderately affecting short-term performance and sentiment.

20 Apr

4

Community Health Systems, Inc. (CYH) invests in ambulatory surgery centers to fuel strategic growth. Strategic investments in high-margin ambulatory surgery centers enable expansion into growing outpatient sector, significantly enhancing CYH's competitive position and long-term performance.

2 Apr

3

Community Health Systems, Inc. (CYH) continues its divestiture efforts by selling a facility in Alabama, sustaining its strategy to offload assets. Divestiture of the Alabama facility aids CYH's debt reduction and operational streamlining, moderately impacting financial performance.

3

Community Health Systems, Inc. (CYH) closed the sale of its Alabama hospital. Closing the hospital sale supports debt reduction and financial streamlining but does not fundamentally alter CYH's overall operations or trajectory.

9 Mar

3

Community Health Systems (CYH) plans to sell four hospitals in Arkansas. Divestiture of four hospitals aids debt reduction and refocuses operations with moderate financial impact.

stockrow.com/CYH · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com